SEER Logo

Seer, Inc. (SEER) 

NASDAQ
Market Cap
$139.75M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
705 of 774
Rank in Industry
389 of 432

Largest Insider Buys in Sector

SEER Stock Price History Chart

SEER Stock Performance

About Seer, Inc.

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and …

Insider Activity of Seer, Inc.

Over the last 12 months, insiders at Seer, Inc. have bought $0 and sold $188,865 worth of Seer, Inc. stock.

On average, over the past 5 years, insiders at Seer, Inc. have bought $34.35M and sold $70.26M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 40,000 shares for transaction amount of $97,968 was made by Farokhzad Omid (CEO, President and Chair) on 2023‑08‑23.

List of Insider Buy and Sell Transactions, Seer, Inc.

2024-06-14Saledirector
12,109
0.0183%
$1.78$21,512+1.12%
2024-03-07SaleCEO AND CHAIR
52,857
0.0808%
$2.03$107,421-11.06%
2024-02-22SalePRESIDENT & CFO
12,684
0.0213%
$1.58$20,024+17.20%
2024-02-22SaleCHIEF LEGAL OFFICER
12,684
0.0213%
$1.58$20,024+17.20%
2024-02-05SalePresident and CFO
3,608
0.0053%
$1.67$6,015+8.68%
2023-12-04SaleChief Legal Officer
8,182
0.0136%
$1.70$13,869+6.16%
2023-08-23PurchaseCEO, President and Chair
40,000
0.0641%
$2.45$97,968-24.27%
2023-05-18SaleChief Commercial Officer
1,468
0.0023%
$3.56$5,224-46.68%
2023-02-21SaleCEO, President and Chair
13,840
0.0229%
$4.13$57,210-33.76%
2023-02-21SaleChief Financial Officer
5,951
0.0098%
$4.13$24,606-33.76%
2023-02-21SaleGeneral Counsel and Secretary
5,951
0.0098%
$4.13$24,603-33.76%
2023-02-07SaleCEO, President and Chair
8,379
0.0129%
$4.67$39,128-38.28%
2023-02-07SaleChief Financial Officer
3,124
0.0056%
$5.40$16,861-38.28%
2023-01-17SaleCEO, President and Chair
4,800
0.0071%
$5.12$24,573-34.47%
2023-01-17SaleChief Financial Officer
2,602
0.0039%
$5.12$13,320-34.47%
2022-12-08SaleChief Financial Officer
18,884
0.0303%
$6.57$124,070-40.94%
2022-06-08SaleGeneral Counsel and Secretary
8,185
0.0128%
$8.91$72,923-31.84%
2022-05-27SalePresident & COO
4,441
0.0065%
$8.06$35,794-27.01%
2022-04-20SalePresident & COO
52,042
0.0833%
$10.18$529,933-29.12%
2022-02-02SaleChief Financial Officer
2,944
0.0046%
$17.40$51,226-52.10%

Insider Historical Profitability

<0.0001%
Farokhzad OmidCEO AND CHAIR
1436285
2.4358%
$2.3717
Invus Public Equities, L.P.10 percent owner
5588366
9.4772%
$2.3711<0.0001%
aMoon Growth Fund Limited Partnership10 percent owner
810961
1.3753%
$2.3721<0.0001%
MCGUIRE TERRANCEdirector
78947
0.1339%
$2.3710<0.0001%
AINSLIE LEE S III10 percent owner
22620
0.0384%
$2.3710<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$10.73M8.75.65M-2.46%-$270,577.13<0.0001
Softbank Group Corp$9.76M7.915.14M0%+$00.05
Artal Group S A$9.03M7.324.75M0%+$00.04
The Vanguard Group$5.01M4.062.64M+0.99%+$49,293.60<0.0001
Capital World Investors$3.91M3.172.06M0%+$0<0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.